Psoriatic Arthritis
Conference Coverage
VIDEO: Guselkumab bests placebo in psoriatic arthritis
MADRID – The IL-23 blocker bested placebo on ACR 20 response and each secondary endpoint.
Conference Coverage
VIDEO: Rheumatology biosimilars gain U.S. momentum
The effect of biosimilars on biologic affordability has just gotten started in the United States but could change soon as more come to market.
Conference Coverage
Pain often persists despite biologic treatment in PsA
MADRID – Psoriatic arthritis patients may have more than just inflammatory pain symptoms.
Conference Coverage
EULAR program features novel treatments and targets in immune pathways and key overviews of the field
As EULAR celebrates its 70th anniversary, it will launch its first awareness campaign‚ “Don’t delay, connect today!” at the congress.
From the Journals
Experts endorse routine screening for pediatric psoriasis comorbidities
Here’s what to look for when screening for comorbidities in pediatric psoriasis patients.
From the Journals
Adalimumab outperforms methotrexate in treating severe pediatric plaque psoriasis
A phase III study provided promising data on the efficacy of adalimumab in children and adolescents with severe plaque psoriasis.
Conference Coverage
Some data support botulinum toxin for psoriasis and rosacea
ORLANDO – Can psoriasis and rosacea symptoms be significantly improved with neuromodulator treatment?
From the Journals
Study underscores antipsoriatic effect of gastric bypass surgery
Psoriasis improvement may be based on postoperative hormonal changes plus weight loss.
News
Renflexis approved as second infliximab biosimilar
Infliximab-abda is approved for all indications as reference product, including Crohn’s diseases in adults and children, ulcerative colitis,...
From the Journals
Risankizumab tops ustekinumab in phase II psoriasis trial
In a phase II study, 77% of patients treated with an investigational agent, risankizumab, achieved least a PASI 90 response at 12 weeks, compared...
Conference Coverage
How to get the most out of methotrexate for psoriasis
WAILEA, HAWAII – Methotrexate is the most cost-effective way to manage extensive psoriasis.